JindeelANaraharaKA. Nontraumatic amputation: incidence and cost analysis. Int J Low Extrem Wounds. 2012;11:177-179.
2.
DillinghamTRPezzinLEShoreAD. Reamputation, mortality, and health care costs among persons with dysvascular lower-limb amputations. Arch Phys Med Rehabil. 2005;86:480-486.
3.
GerdthamUGClarkePHayesAGudbjornsdottirS. Estimating the cost of diabetes mellitus-related events from inpatient admissions in Sweden using administrative hospitalization data. Pharmacoeconomics. 2009;27:81-90.
4.
Ziegler-GrahamKMacKenzieEJEphraimPLTravisonTGBrookmeyerR. Estimating the prevalence of limb loss in the United States: 2005 to 2050. Arch Phys Med Rehabil. 2008;89:422-429.
5.
DillinghamTPezzinLMacKenzieE. Incidence, acute care length of stay, and discharge to rehabilitation of traumatic amputee patients: an epidemiologic study. Arch Phys Med Rehabil. 1998;79:279-287.
6.
DillinghamTRPezzinLEMacKenzieEJ. Limb amputation and limb deficiency: epidemiology and recent trends in the United States. South Med J. 2002;95:875-883.
7.
Centers for Disease Control and Prevention. Crude and age-adjusted hospital discharge rates for nontraumatic lower extremity amputation per 1,000 diabetic population, United States, 1988-2006. http://www.cdc.gov/diabetes/statistics/lea/fig3.htm. Accessed March 24, 2013.
8.
EslamiMHZayaruznyMFitzgeraldGA. The adverse effects of race, insurance status, and low income on the rate of amputation in patients presenting with lower extremity ischemia. J Vasc Surg. 2007;45:55-59.
